Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

Project cooperationUpdated on 8 October 2026

Collaboration in research projects

CEO-Co-founder at Aequilibria Health

Rome, Italy

About

Open to research and clinical collaborations to include our innovative digital neurotherapy app, Frequentia, designed to bring laboratory-grade 40 Hz gamma brainwave entrainment directly to consumers and patients via smartphones.

By combining multisensory controlled stimulation, Frequentia non-invasively stimulates 40 Hz gamma oscillations in the brain. Gamma brainwaves are critical for executive function, memory processing, and neural synchronization.

Rather than replacing primary care protocols, Frequentia is designed to run in parallel with standard-of-care pharmacotherapies, lifestyle interventions, or cognitive rehabilitation programs—offering an accessible, home-based digital therapeutic tool.

Ideal Study Areas & Target Applications

  1. Neurodegenerative & Memory Studies: Investigating the impact of 40 Hz gamma entrainment on early-stage cognitive decline or subjective cognitive complaints.

  2. Stress, Burnout & Executive Function: Assessing cognitive resilience, fatigue recovery, and daily focus in high-stress populations or healthy aging cohorts.

  3. Sleep & Circadian Rhythms: Evaluating multisensory entrainment effects on sleep quality, mood regulation, and autonomic function.

Type

  • Market Access
  • Strategic Partnership
  • Technological contribution

Similar opportunities